Empagliflozin Superior to Placebo for Heart Failure
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes
Only registered members have full access to PracticeUpdate content.